Nutritional psychiatry — the systematic study of how dietary patterns affect psychiatric illness and cognitive trajectory — has matured from a fringe area into a recognized clinical sub-discipline with substantial evidence base. The field encompasses everything from the well-established protective effects of the Mediterranean diet to the more recent and intense investigation of ketogenic interventions in refractory psychiatric illness. The clinical task is to translate the evidence into conversations that patients can actually act on, in a domain where compliance and individual variation are substantial.
The Mediterranean diet has the strongest population-level evidence for mental and cognitive health benefit. Multiple large prospective studies, including PREDIMED and others, have shown that Mediterranean dietary patterns are associated with reduced incidence of depression, slower cognitive decline, and reduced dementia incidence. The pattern — vegetables, fruits, whole grains, fish, olive oil, nuts, moderate alcohol, limited processed food and red meat — is broadly tolerable, accessible, and adaptable to many cultural contexts. For most patients in the acceleration window, this is the dietary baseline the clinical conversation starts with.
Ultra-processed food avoidance has emerged as one of the more important dietary signals in recent research. The category — foods with industrial ingredient lists, additives not used in home kitchens, multiple steps of industrial processing — appears to contribute to mental health risks beyond what their macronutrient composition alone would predict. The mechanism is multimodal: inflammation, microbiome disruption, hyperpalatability driving overconsumption, additive effects, and substitution effect (more ultra-processed food means less whole food). The clinical recommendation that emerges is simple: minimize ultra-processed food consumption regardless of other dietary choices.
The ketogenic intervention sits at a different point in the evidence spectrum — strong mechanistic rationale, accumulating clinical evidence in refractory cases, not yet a first-line recommendation for typical depression or anxiety. The applications, implementation, and caveats are covered in detail in L5.3. The key clinical point is that ketogenic intervention is a treatment for selected refractory cases, not a generic recommendation; for the typical patient, the Mediterranean baseline with ultra-processed food minimization is the more appropriate starting point.
Specific nutrients and supplements with reasonable evidence for psychiatric application include: Omega-3 fatty acids (EPA-predominant formulations, 1–2g EPA daily) for mood disorders, particularly bipolar and treatment-resistant depression. Vitamin D repletion in deficient patients, though the evidence for supplementation in already-replete patients is weak. Magnesium (often deficient in the modern diet) with modest evidence for anxiety and sleep. B12 and folate repletion in deficient patients, with methylated forms (methylcobalamin, methylfolate) preferred in patients with MTHFR variants. Saffron extract with small but real evidence for depression. Probiotics with emerging evidence (covered in L17.2) for anxiety and mood.
The clinical conversation about diet is delicate. Dietary recommendations interact with eating disorder pathology, socioeconomic constraints, cultural food traditions, family dynamics, and the patient's existing relationship with food. The clinician who delivers dietary advice with the authority of a prescription, without attention to these contextual factors, frequently produces resistance, shame, and non-adherence rather than dietary change. The skilled clinical move is to introduce the evidence, frame the relevant changes, and partner with the patient on what is realistically achievable for them — recognizing that imperfect adherence to good dietary direction is far better than perfect adherence to no direction at all.